BIODEXA PHARMACETICALS reports a Return on Equity (ROE) of -54.85%.

What is BDRX's dividend yield?

BIODEXA PHARMACETICALS offers a dividend yield of 0.00%.

What is BDRX's Deepscope Quality Score?

Deepscope rates BDRX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BDRX?

Deepscope's AI Timing Score for BDRX is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BDRX belong to?

BIODEXA PHARMACETICALS is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu BDRX (NASDAQ) | BIODEXA PHARMACETICALS

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2025-12-31)

BDRX

BIODEXA PHARMACETICALS

US:NASDAQ STOCK Healthcare >> Biotechnology News 50

USD 3.59

0.09 (2.57%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-54.9%

ROE

-34.4%

ROA

0.00%

Div Yield

BIODEXA PHARMACETICALS
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.59 Price 0.09 (2.57%) Day Change	NEWS SCORE: 50

BDRX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	50
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.59
PBV / Sector	0.01 / 4.48 GREAT
Earning Per Share	-113.82

PE / Sector	N/A / 16.68
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	0.19 M GREAT
Average 1W Daily Value	0.09 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.37
NPM Average (%) / Sector	-1,476.64 / -1,506.30
NPM Change Average (%) / Sector	N/A / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-34.41 / 30.83
ROA Average (%) / Sector	-69.72 / -347.12
ROA Change Average (%) / Sector	-35.02 / 5,126.35
ROE (%) / Sector	-54.85 / -3.04
ROE Average (%) / Sector	-129.28 / 40.76
ROE Change Average (%) / Sector	-37.45 / 2,110.63
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Chi tiết đăng ký

Analyze Date	2026-06-04 09:23:39
Symbol	BDRX
Name	BIODEXA PHARMACETICALS
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	0.75 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	0.16 / 8,483.11

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ

Phone: 44 29 2048 0180

Website: https://www.biodexapharma.com

Sector: Healthcare >> Biotechnology

Description: Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of recurrent glioblastoma, diffuse midline glioma, and medulloblastoma; and MTX240, for the treatment of gastrointestinal stromal tumors. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release therapeutics; MidaSolve, nanotechnology used to dissolve insoluble drugs so that they can be administered in liquid form directly and locally into tumours; and MidaCore, a gold nanoparticle used for targeting sites of disease. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.